VIVUS, Inc. (NASDAQ:VVUS)

CAPS Rating: 2 out of 5

A pharmaceutical company dedicated to the development and commercialization of therapeutic products using patented proprietary formulations and novel delivery systems and by seeking new indications for previously approved pharmaceutical products.

Recs

0
Player Avatar copydog1981 (< 20) Submitted: 7/8/2010 6:16:44 AM : Underperform Start Price: $11.12 VVUS Score: -97.68

I guess it wil not get the approval they are looking for

Featured Broker Partners


Advertisement